Xin Lang Cai Jing·2025-09-30 08:55Core Viewpoint - Shandong Weigao Blood Purification Products Co., Ltd. announced the results of its 2025 restricted stock incentive plan, granting 6.36 million shares at a price of 19.77 yuan per share, aimed at enhancing employee motivation and long-term performance [1] Group 1: Incentive Plan Details - The company determined to grant 6.36 million restricted shares to 120 incentive recipients [1] - The grant price is set at 19.77 yuan per share, with the stock sourced from a directed issuance of A-share common stock [1] - The maximum validity period of the incentive plan is 48 months, with a lock-up period starting from the registration date and a minimum gap of 12 months before the first release of restrictions [1] Group 2: Financial Implications - The registration was completed on September 29, raising 125.7 million yuan for liquidity support [1] - The equity structure will see an increase of 6.36 million restricted shares [1] - The cost of the incentive plan will be accounted for in expenses, which will impact net profit in various years [1]